Drug and vaccine authorizations for COVID-19: Overview

Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks.

Data and Resources

Additional Info

Field Value
Source
Version None
Author None
Author Email None
Maintainer None
Maintainer Email None
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French)
Update Frequency
Geographic Scope
Criticality Level
Sensitivity Level
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published
Open Canada Date Modified
Open Canada Subject
Open Canada Keywords
Open Canada Collection
Principal Organization
Reference Data
Official Source